Almi Invest — 2021 Investments
3 investments dated 2021 · listed companies and verified rows first · show all
ApoGlyx develops small-molecule aquaporin-9 inhibitors to treat severe inflammatory and metabolic diseases, including acute pancreatitis and diabetes.
BiotechHealthtechMedical DevicesAarhus, DK
Michael Rützler(Chief Executive Officer & Co-founder)inSøren Nielsen(Co-founder)
Co-investorsLU Innovation
Klimato builds data infrastructure and emissions reporting tools for food businesses to measure and reduce their climate impact.
Climate TechFoodTechSaaSStockholm, SE
Anton Unger(Founder)in
Co-investorsGlobal Cleantech Capital
Limina provides investment management software that automates workflows for portfolio managers and operations teams across front, middle, and back office functions.
Enterprise SoftwareFintechSaaS
Co-investorsGoose Valley VenturesIndustrifondenVidici Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.